Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
2022 · Journal of Hematology & Oncology · 332 citations
https://doi.org/10.1186/s13045-022-01391-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
392
Citations
2
h-index
2
i10-index
Fachao Xie is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Melanoma and MAPK Pathways. The author has an h-index of 2, co-authored 2 publications.
https://doi.org/10.1186/s13045-022-01391-4
https://doi.org/10.1038/s41392-023-01545-x
Click to start Chat